Kang is called to the Bars of Ontario and Quebec. He was named “2022 IFLR Rising Star (Americas)” by the London-based International Financial Law Review. He is a graduate of Queen’s University (J.D.) and of University of Montreal (LL.B.). He also holds a B.Sc. in biochemistry from McGill University. »
Prior to joining JAMP Pharma Group, Kang worked for several years for a large Canadian law firm and a multinational pharmaceutical company. He joined JAMP Pharma Group in January 2019 as Senior Legal Counsel and Chief Legal Officer. He has served as Vice President, Global Legal Affairs and Intellectual Property since November 2021. He is responsible for legal files related to intellectual property and related cross-border issues. His approach to legal affairs is to promote a holistic and pragmatic solution tailored to the pharmaceutical field, a complex and highly regulated industry.